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ABSTRACT 
The synthesis of natural products and biologically active molecules is one of the main 
applications of organic chemistry. Many natural products with valuable biological properties have 
low abundance in natural sources. Therefore, they need to be synthesized in sufficient quantities 
that their properties and activities can be studied. Chapter 1 describes synthesis of a library of 
biologically active compounds which are currently used in RNA imaging studies. Chapter 2 
describes the synthesis of the procyanidin A skeleton. Procyanidins are important natural products 
with various biological activities. Chapter 3 describes a method for the preparation of 
anthocyanidins, natural products which possess valuable biological properties.
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GENERAL INTRODUCTION 
The synthesis of natural products and biologically active molecules is one of the main 
applications of organic chemistry. Many natural products with valuable biological properties have 
low abundance in natural sources. Therefore, they need to be synthesized in sufficient quantities 
that their properties and activities can be studied. Bioactive small molecules can be utilized in 
studying different biological processes such as transcription of RNA. Understanding these 
processes will allow the development of new therapies and drugs. The synthesis should be 
efficient, simple, with the use of environmentally friendly reagents and follow the principles of 
green chemistry. Therefore, products should be synthesized in good yields and be easy to purify. 
In this thesis, we report new synthetic methods that were used towards the syntheses of 
natural products and molecules for RNA imaging. Chapter 1 describes synthesis of a library of 
biologically active compounds which are currently used in RNA imaging studies by our 
collaborators in the Department of Biochemistry, Biophysics and Molecular Biology at Iowa State 
University. Also, we have developed a method for labelling of aminoglycosides with fluorinated 
esters. This method is used by our collaborators at the University of California San Francisco who 
use radiolabeled esters to track bacteria in soil. Some of this work has been published in Methods 
in 2016 (Ilgu, M.; Ray, J.; Bendickson, L.; Wang, T.; Geraskin, I. M.; Kraus, G. A.; Nilsen-
Hamilton, M. Methods, 2016, 98, 26-33.).  Chapter 2 describes the synthesis of the procyanidin A-
skeleton. Procyanidins are important natural products with various biological activities. This 
method is operationally simple, efficient, and can be performed on a large scale and used for the 
total synthesis of A-type procyanidins. This work has been published in Tetrahedron Letters in 
2017 (Kraus, G. A.; Geraskin, I. M. Tetrahedron Letters, 2017, 58, 4609–4611.).  In chapter 3 we 
report the method for the preparation of anthocyanidins, natural products which possess valuable 
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biological properties, from benzopyrans. This method is efficient one-pot transformation which 
can be used for the synthesis of anthocyanidins on a large scale. This work has been published in 
Natural Product Communications in 2016 (Kraus, G. A.; Geraskin, I. M. Natural Product 
Communications 2016, 11, 1649-1650.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
CHAPTER 1. SYNTHESIS OF SMALL MOLECULES FOR RNA IMAGING 
Some of this work has been published in Methods in 2016 (Ilgu, M.; Ray, J.; Bendickson, L.; 
Wang, T.; Geraskin, I. M.; Kraus, G. A.; Nilsen-Hamilton, M. Methods, 2016, 98, 26-33.). 
 
Introduction 
RNA molecules participate in and regulate many fundamental cellular processes. To gain 
better understanding of the variety of RNA functions, the entire cellular life of RNAs, from their 
synthesis to their decay, needs to be examined. Thus, the ability to image RNA transcription and 
trafficking in real time and in living cells will allow researchers to investigate many cellular 
processes involving RNAs. The RNA molecule is not fluorescent by itself.  There are several 
strategies for fluorescent imaging of RNA. One of them requires the expression of an exogenous 
transcript of interest fused to an aptamer sequence, known as chimeric transcript. The aptamer 
itself is not fluorescent, but when it binds a specific protein partner fused to an autofluorescent 
protein (chimeric protein), the entire system becomes fluorescent after excitation at appropriate 
wavelength. The main drawbacks of aptamer-protein systems are the strong background signal 
produced by the constant fluorescence of the chimeric protein not bound to the aptamer and 
proteins bound to RNA can participate in interactions with other cell elements. One of the 
examples of proteins which was extensively used for RNA imaging is green fluorescent protein 
(GFP).1 
Another strategy utilizes fluorescent molecules, ligands, which have affinity to certain 
regions of RNA, so-called light-up aptamers.2 These ligands become more fluorescent upon 
binding to aptamers and the ligand-aptamer complex can be visualized by fluorescence 
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microscopy. There are many reports on the discovery of aptamers that bind fluorophores which 
enables RNA imaging. Some of them include aptamers that bind triphenylmethanes, 
bisbenzimides, benzothiazolidene asymmetric cyanine dye, and thiazole orange.3-5 Recently, 
Jaffrey and coworkers reported RNA aptamers, denoted as Spinach and Spinach 2, that bind (Z)-
5-(4-HydroxyBenzylidene)-2,3-dimethyl-3,5-dihydro-4H-Imidazol-4-one (HBI), compound 1, 
and (Z)-4-(3,5DiFluoro-4-HydroxyBenzylidene)-1,2-dimethyl-1H-Imidazol-5(4H)-one DFHBI, 
compound 2, fluorophores mimicking the fluorophore present in GFP (Figure 1).6  HBI 
corresponds to the fragment of GFP responsible for its fluorescence.7 
 
The advantage of this strategy is that ligands are small molecules which typically do not 
participate in non-RNA binding interactions and can be modified to produce better fluorescence 
and affinity. 
Another technique to utilize small molecules for RNA imaging is FRET. FRET, Förster 
resonance energy transfer, is a mechanism describing energy transfer between two light-sensitive 
molecules.8 The mechanism of transfer occurs when the donor, in its excited state, transfers energy 
non-radiatively to a neighboring molecule, the acceptor, in its ground state via dipole-dipole 
interactions.9 The advantage of FRET is that there is no background fluorescence coming from 
ligands not bound to RNA because fluorescent visualization occurs only when two molecules, 
donor and acceptor, are in close proximity to each other.10 
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Results and discussion 
We have been exploring DFHBI platform in order to create better fluorescent probes for 
RNA imaging in live cells. First, we have synthesized HBI analogs with R group being long chain 
and branched alkyl, alkynyl and aryl in order to test binding affinities of synthesized ligands to 
Spinach, Spinach 2 aptamers, Scheme 1. A library of HBI analogs was synthesized by the reaction 
of azalactone 3, which is readily available from 4-hydroxy-benzaldehyde and N-acetylglycine, 
with the corresponding primary amines in the presence of base, as shown in Scheme 1. 
 
The synthesized analogs and yields are listed in Table 1. 
Table 1. Synthesized HBI analogs. 
Entry Amine Product Compound Yield, % 
1 t-BuNH2 
 
4 52 
2 Propargyl amine 
 
5 57 
    
6 
 
Table 1. (continued) 
3 
 
 
6 73 
4 C8H17NH2 
 
7 85 
 
It was found that compound 6, HBI analog with R = 2,4-dimethoxybenzene, had the highest 
binding affinity towards Spinach and Spinach 2 aptamers (Table 1, entry 3). Considering this 
result, various DFHBI analogs with different aryl groups, replacing methyl group on amide 
nitrogen of DFHBI azalactone ring, were synthesized in a similar fashion in order to find one 
which will give the highest fluorescence, as shown in Table 2. 
Table 2. Synthesized DFHBI analogs. 
 
Entry Amine Product Compound Yield, % 
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Table 2. (continued) 
1 CH3NH2 
 
9 61 
2 
 
 
10 43 
3 
 
 
11 71 
4 
 
 
12 75 
5 
 
 
13 52 
6 
 
 
14 72 
 
 
 
   
8 
 
Table 2. (continued) 
7 
 
 
15 78 
8 
 
 
16 77 
9 
 
 
17 53 
10 
 
 
18 73 
11 
 
 
19 73 
12 
 
 
20 75 
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Table 2. (continued) 
13 
  
21 71 
14 
 
 
22 63 
15 
 
 
23 73 
16 
 
 
24 69 
17 
 
 
25 70 
 
The best DFHBI analog, with the highest affinity towards Spinach and Spinach 2 RNA 
aptamers, and fluorescent yield, was found to be PFP-DFHBI, compound 21.11, 12 This new ligand 
has superior qualities compared to commonly used DFHBI and can be used for fluorescent imaging 
of RNA. It has three-fold higher fluorescence compared to DFHBI which makes it to be more 
useful ligand.  
10 
 
 In order to further explore DFHBI platform we were able to functionalize the allylic 
position in HBI. Treatment of HBI with two equivalents of LDA formed the dianion which 
selectively reacted with various aldehydes at the allylic position forming aldol condensation 
products (Scheme 3, Table 3, Entries 1-3). The high selectivity of the reaction can probably be 
best explained by electrostatic repulsion of negative charges in dianion making second negative 
charge to be formed selectively at the allylic position, as far away as possible from the phenolate. 
 
The scope of the reaction can be extended further by using various electrophiles. 
Allylation of HBI using allyl bromide afforded compound 28 in moderate yield (Table 3, entry 4). 
Similarly, treatment of HBI with two equivalents of LDA followed by addition of diphenyl 
disulfide or diphenyl diselenide gave compounds 29, 30, 31 respectively (Table 3, entries 5, 6). 
Interestingly, when diphenyl disulfide was used as an electrophile small portion of bis-organo-
sulfidation product was isolated due to sulfur lowering the pKa of adjacent methylene hydrogens 
(Table 3, entry 6). 
Table 3. Synthesized DFHBI analogs. 
Entr
y 
Electrophile Product Comp
ound 
Yiel
d 
(%) 
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Table 3. (continued) 
 
1 
 
 
26 91 
2 
 
 
27 48 
3 
 
 
28 63 
4 
 
 
29 44 
5  
 
30 31 88 
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Table 3. (continued) 
 
6  
 
32 55 
 
The same reaction conditions can be applied for the functionalization of the allylic position 
in DFHBI (Scheme 4). 
 
When TBS-protected HBI, compound 34, was treated with one equivalent of LDA, 
followed by the addition of benzaldehyde, very low selectivity was observed, Scheme 5. 
Compound 35 was isolated in 26% yield and complex mixture of products was obtained. 
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These compounds, DFHBI analogs modified at the allylic position, were found to have less 
binding affinity towards Spinach, Spinach 2 RNA aptamers than PFP-DFHBI, compound 21. 
Fortunately, compounds 26, 27, 28, 33 have been found to have interesting photophysical 
properties due to extended conjugation. Namely, they have different excitation and emission 
wavelengths compared to DFHBI and were found to have longer fluorescence lifetime. The studies 
are currently conducted to explore the full potential of these compounds. 
After finding DFHBI ligands with the highest affinity towards Spinach 1 and Spinach 2 
aptamers, the ones having substituted benzyl groups in place of methyl group on amide nitrogen 
of DFHBI azalactone ring, we have attached cyanine dyes to generate the desired FRET pair. Cy3, 
Cy5 fluorescent dyes were employed to form the FRET pair, where Cy3 acts as the donor and Cy5 
as the acceptor, Figure 2. Both non-sulfonated and sulfonated versions of the dyes are 
commercially available in their NHS ester forms and were employed for the labelling of the 
DFHBI derivatives. The best FRET signal was observed in vitro when sulfonated Cy3, Cy5 dyes 
were used, most likely because of their better water-solubility. 
14 
 
 
NHS esters are known for their selective reactivity towards primary amino groups in the 
presence of other nucleophiles. DFHBI ligands with protected primary amino group on benzyl ring 
were synthesized, Scheme 6. Monoprotected amines 36, 37 were prepared in good yields by the 
reaction of the corresponding diamines with one equivalent of di-tert-butyl decarbonate in dioxane. 
Azalactone 8 was treated with monoprotected amines 36, 37 in the presence of potassium 
carbonate at reflux in ethanol to afford 3-bocaminobenzylamine DFHBI 38 and 4-
bocaminophenylbenzylamine DFHBI 39. 
15 
 
 
Deprotection of Boc group in 3-aminobenzylamine DFHBI 38 with trifluoroacetic acid 
liberated primary amino group which selectively reacted with Cy3 NHS ester or Cy5 NHS ester to 
give 3-bocaminobenzylamine DFHBI-Cy3 40 and 3-aminobenzylamine DFHBI-Cy5 41, Scheme 
7. Similarly, another FRET pair, 4-aminophenylbenzylamine DFHBI-Cy3 42 and 4-
aminophenylbenzylamine DFHBI-Cy5 43, was generated by deprotection of primary amino group 
in 4-bocaminophenylbenzylamine DFHBI 39, followed by the reaction with Cy3 or Cy5 NHS 
esters, Scheme 8. 
16 
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In order to select novel RNA aptamers from pool of RNAs, which bind DFHBI ligands and 
can expand their applications, biotin needs to be attached to these ligands. The same synthetic 
strategy as one for attaching cyanine dyes to DFHBI analogs, utilizing selective affinity of NHS 
esters to primary amino groups, was employed. Treatment of 3-bocaminobenzylamine DFHBI 38 
with TFA followed by the reaction with biotin NHS ester in the presence of triethyl amine afforded 
3-aminobenzylamine DFHBI-biotin 44 in quantitative yield, Scheme 9. Similarly, 4-
aminophenylbenzylamine-biotin 45 was synthesized by treatment of 4-
bocaminophenylbenzylamine DFHBI 39 followed by reaction with biotin NHS ester in the 
presence of triethyl amine. 
 
 
The studies are currently conducted by our collaborators at Iowa State University, 
Department of Biochemistry, Biophysics and Molecular Biology to select new RNA aptamers for 
newly synthesized DFHBI ligands using compounds 44 and 45. 
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Our collaborators from the University of California in San Francisco study various bacteria 
in soil. In order to track these bacteria different techniques can be used such as fluorescence, 
radiolabeling. We have developed procedures for labelling of aminoglycosides which can be 
applied for tracking bacteria in soil. NHS ester protocol employed for coupling of DFHBI to 
cyanine dyes and biotin was utilized to attach fluorobenzoyl moiety to tobramycin, as shown in 
Scheme 10. NHS esters of fluorobenzoic acids are readily available by treatment of the 
corresponding fluorobenzoic acids with N-hydroxysuccinimide in the presence of DCC. NHS 
esters of fluorobenzoic acids reacted with primary amino group of tobramycin with complete 
regioselectivity. Other reaction conditions (benzoyl chloride/triethyl amine) employed for 
functionalization of primary amino group did not provide satisfactory selectivity and resulted in 
mixture of products. Tobramycin can be radiolabeled with fluorobenzoyl moiety bearing 
radioactive isotope 18F using this method and can be used to study bacteria in soil. 
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Tobramycin was coupled with Cy3, Cy5 cyanine dyes to generate FRET pair, Scheme 11. 
Tobramycin reacted with Cy3 NHS ester or Cy5 NHS ester regioselectively at primary amino 
group to yield tobramycin-Cy3 46 or tobramycin-Cy5 47. 
 
Primary amino group in paromomycin, another aminoglycoside, was functionalized with 
4-hydroxyphenylpropionate using Bolton-Hunter reagent, Scheme 12. Compound 48 is readily 
available by treatment of 4-hydroxyphenylpropionic acid with N-hydroxysuccinimide in the 
presence of DCC. 
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Studies of interactions of these functionalized aminoglycosides and bacteria in soil are 
currently conducted by our collaborators at the University of California in San Francisco. 
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Conclusion 
In summary, we have synthesized a number of DFHBI analogs. Some of the synthesized 
analogs, compounds 11-22, have superior qualities compared to DFHBI. The best DFHBI analog, 
PFP-DFHBI, compound 21, has three-fold higher fluorescence compared to DFHBI which makes 
it to be more useful for fluorescent visualization of gene expression. The synthesized analogs can 
be used as either light-up aptamers or via FRET for the visualization of gene expression. We have 
successfully coupled Cy3 and Cy5 dyes to newly synthesized ligands, compounds 38, 39, to 
generate a FRET pair for imaging. Biotin has been attached to these ligands to select novel RNA 
aptamers from pool of RNAs. 
A new chemistry has been developed allowing functionalization of DFHBI at the allylic 
position. Some of the synthesized compounds have been found to have different excitation and 
emission wavelengths compared to DFHBI and longer fluorescence lifetime. These properties can 
be useful for imaging of biological molecules. The studies are currently conducted to explore the 
full potential of these compounds. 
We have developed procedures for labelling aminoglycosides which can be applied for 
tracking bacteria in soil. We have developed procedure to radiolabel tobramycin with 
fluorobenzoyl moiety bearing 18F fluorine isotopes. Also, tobramycin was coupled with Cy3, Cy5 
cyanine dyes to generate FRET pair. Paromomycin was labelled with Bolton-Hunter reagent. 
These labelled aminoglycosides are being studied how they interact with bacteria in soil. 
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Experimental Section 
All starting materials were purchased from Sigma-Aldrich; solvents were purchased from 
Fisher Scientific and used without further purification. All reactions were carried out in flame-
dried glassware under argon with dry solvents under anhydrous conditions. All yields refer to 
chromatographically isolated products. Reactions were monitored by thin-layer chromatography 
(TLC) carried out on 0.20 mm silica gel plates using UV light as a visualizing agent. Silica gel 
60A, particle size 0.032 – 0.063 mm, was used for flash column chromatography. 1H and 13C NMR 
spectra were acquired in CDCl3 on a Varian MR-400 spectrometer. 
1H and 13C chemical shifts (δ) 
are given in ppm relative to the residual protonated solvent peak (CDCl3: δH = 7.26 ppm, δC = 
77.0 ppm; CD3OD: δH = 3.31 ppm, δC = 49.0 ppm) as an internal reference. High-resolution mass 
spectra (HRMS) were recorded on an Agilent 6540 QTOF (quadrupole time of flight) mass 
spectrometer using ESI (electrospray ionization) or APCI (atmospheric-pressure chemical 
ionization), or EI (electron ionization) on an Agilent 6890 GC/MS. IR were recorded on Nicolet 
Fisher Scientific iS5. Melting points were measured on Mel-Temp II melting point apparatus. 
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(Z)-4-((2-methyl-5-oxooxazol-4(5H)-ylidene)methyl)phenyl acetate 3. Yellow solid. 86% 
yield. This compound was prepared according to the literature procedure and showed 
spectroscopic data identical to previously reported.13 
 
(Z)-5-(4-hydroxybenzylidene)-2,3-dimethyl-3,5-dihydro-4H-imidazol-4-one 1. Yellow solid. 
56% yield. This compound was prepared according to the literature procedure and showed 
spectroscopic data identical to previously reported.13, 14 
Procedure 1. General procedure for the synthesis of HBI analogs. 
 
To azalactone 3 (0.5 g, 2.04 mmol) in ethanol (10 mL) the corresponding amine (2.45 mmol) was 
added followed by potassium carbonate (0.4227 g, 3.06 mmol). The reaction was refluxed 
overnight. The solvent was evaporated. Water was added (30 mL). pH was adjusted to 3 with 1M 
HCl. The product precipitated out of the solution. The crude product is filtered, dried. The product 
was purified by preparative TLC. 
24 
 
 
(Z)-3-(tert-butyl)-5-(4-hydroxybenzylidene)-2-methyl-3,5-dihydro-4H-imidazol-4-one 4. 
Yellow solid. 52 % yield. 1H NMR (400 MHz, CD3OD): δ 7.49 (d, J = 8.5 Hz, 2H, ArH), 7.39 (s, 
1H), 6.81 (d, J = 8.5 Hz, 2H, ArH), 2.16 (s, 3H), 1.29 (s, 9H).   
 
(Z)-5-(4-hydroxybenzylidene)-2-methyl-3-(prop-2-yn-1-yl)-3,5-dihydro-4H-imidazol-4-one 
5. Yellow solid. 57% yield. 1H NMR (400 MHz, CD3OD): δ 8.01 (d, J = 8.8 Hz, 2H, ArH), 7.04 
(s, 1H), 6.89 (d, J = 8.8 Hz, 2H, ArH), 4.47 (s, 2H, CH2), 2.80 (s, 1H), 2.48 (s, 3H). 
 
(Z)-3-(2,4-dimethoxybenzyl)-5-(4-hydroxybenzylidene)-2-methyl-3,5-dihydro-4H-imidazol-
4-one 6. Yellow solid. 73% yield. 1H NMR (400 MHz, CD3OD): δ 8.01 (d, J = 8.8 Hz, 2H, ArH), 
7.04 (s, 1H), 7.01 (s, 1H, ArH), 6.85 (d, J = 8.8 Hz, 2H, ArH), 6.56 (s, 1H, ArH), 6.47-6.50 (m, 
1H) 4.77 (s, 2H, CH2), 3.84 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 2.28 (s, 3H). 
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(Z)-5-(4-hydroxybenzylidene)-2-methyl-3-octyl-3,5-dihydro-4H-imidazol-4-one 7. Yellow 
solid. 85% yield. 1H NMR (400 MHz, CD3OD): δ 8.00 (d, J = 8.6 Hz, 2H, ArH), 7.01 (s, 1H), 6.85 
(d, J = 8.7 Hz, 2H, ArH), 3.59 – 3.66 (m, 2H), 3.14 (t, J = 7.1 Hz, 1H, ArH), 2.39 (s, 3H), 1.63 (p, 
J = 7.3 Hz, 2H), 1.48 (p, J = 7.2 Hz, 1H), 1.27 – 1.35 (m, 11H), 0.87 – 0.92 (m, 2H). 
 
(Z)-2,6-difluoro-4-((2-methyl-5-oxooxazol-4(5H)-ylidene)methyl)phenyl acetate 8. Yellow 
solid. 57% yield. This compound was prepared according to the literature procedure and showed 
spectroscopic data identical to previously reported.14  
 
(Z)-5-(3,5-difluoro-4-hydroxybenzylidene)-2,3-dimethyl-3,5-dihydro-4H-imidazol-4-one 9. 
Yellow solid. 61% yield. This compound was prepared according to the literature procedure and 
showed spectroscopic data identical to previously reported.14 
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(Z)-5-(3,5-difluoro-4-hydroxybenzylidene)-2-methyl-3-(2,2,2-trifluoroethyl)-3,5-dihydro-
4H-imidazol-4-one 10. 43% yield. This compound was prepared according to the literature 
procedure with a few modifications. Modifications: DMF was used instead of ethanol as a solvent. 
Reaction was run in a sealable tube at 40 ºC. The compound showed spectroscopic data identical 
to previously reported.15 
Procedure 2. General procedure for the synthesis of DFHBI analogs. 
 
To azalactone 8 (0.200 g, 0.711 mmol) in ethanol (10 mL) was added solution of amine (0.853 
mmol) in ethanol (5 mL) followed by potassium carbonate (0.1474 g, 1.07 mmol). The reaction 
mixture was refluxed for 12 hours. After cooling down to room temperature solvent was 
evaporated. Water (15 mL) was added, pH was adjusted to 3 using 1M HCl. The solution was set 
overnight at 4 °C. The product precipitated out of the solution. The crude product is filtered, dried. 
The product was purified by preparative TLC. 
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(Z)-3-(2,4-dimethoxybenzyl)-5-(4-hydroxybenzylidene)-2-methyl-3,5-dihydro-4H-imidazol-
4-one 11. Orange solid. 71% yield. 1H NMR (400 MHz, CD3OD): δ 8.01 (d, J = 8.8 Hz, 2H, ArH), 
7.04 (s, 1H), 7.01 (s, 1H, ArH), 6.85 (d, J = 8.8 Hz, 2H, ArH), 6.56 (s, 1H, ArH), 6.47-6.50 (m, 
1H) 4.77 (s, 2H, CH2), 3.84 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 2.28 (s, 3H). 
 
(Z)-3-benzyl-5-(3,5-difluoro-4-hydroxybenzylidene)-2-methyl-3,5-dihydro-4H-imidazol-4-
one 12. Orange solid. 75% yield. 1H NMR (400 MHz, CD3OD): δ 7.81 (d, J = 9.8 Hz, 2H, ArH), 
7.37 (t, J = 7.2 Hz, 2H, ArH), 7.31 (d, J = 7.3 Hz, 1H, ArH), 7.26 (t, J = 7.3 Hz, 2H), 6.99 (s, 1H), 
2.28 (s, 3H). HRMS ESI (m/z): calcd. for C18H14F2N2O2 [M + H]
+, 329.1096; found 329.1104. 
 
(Z)-3-(4-aminobenzyl)-5-(3,5-difluoro-4-hydroxybenzylidene)-2-methyl-3,5-dihydro-4H-
imidazol-4-one 13. Yellow solid. 52% yield. 1H NMR (400 MHz, CD3OD): δ 7.81 (d, J = 9.2 Hz, 
2H, ArH), 7.10 (d, J = 8.4 Hz, 2H, ArH), 6.96 (s, 1H), 6.77 (d, J = 8.4 Hz, 2H, ArH), 4.75 (s, 2H), 
2.29 (s, 3H). HRMS ESI (m/z): calcd. for C18H15F2N2O3 [M+H]
+, 345.1045; found 345.1045. 
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(Z)-3-(4-aminobenzyl)-5-(3,5-difluoro-4-hydroxybenzylidene)-2-methyl-3,5-dihydro-4H-
imidazol-4-one 14. Orange solid. 72% yield. 1H NMR (400 MHz, CD3OD): δ 7.79 (d, J = 9.6 Hz, 
2H, ArH), 7.01 (d, J = 8.4 Hz, 2H, ArH), 6.95 (s, 1H), 6.70 (d, J = 8.4 Hz, 2H, ArH), 4.71 (s, 2H), 
2.29 (s, 3H). HRMS ESI (m/z): calcd. for C18H16F2N3O2 [M+H]
+, 344.1205; found 344.1214. 
 
(Z)-5-(3,5-difluoro-4-hydroxybenzylidene)-2-methyl-3-(4-nitrobenzyl)-3,5-dihydro-4H-
imidazol-4-one 15. Orange solid. 78% yield. 1H NMR (400 MHz, CD3OD): δ 8.26 (d, J = 8.4 Hz, 
2H, ArH), 7.82 (d, J = 9.6 Hz, 2H, ArH), 7.52 (d, J = 8.4 Hz, 2H, ArH), 7.01 (s, 1H), 5.01 (s, 2H), 
2.31 (s, 3H). HRMS ESI (m/z): calcd. for C18H14F2N3O4 [M+H]
+, 374.0947; found 374.0950. 
 
(Z)-3-(4-(allyloxy)benzyl)-5-(3,5-difluoro-4-hydroxybenzylidene)-2-methyl-3,5-dihydro-4H-
imidazol-4-one 16. Yellow solid. 77% yield. 1H NMR (400 MHz, CD3OD): δ 7.75 (d, J = 8.0 Hz, 
2H, ArH), 7.16 (d, J = 8.4 Hz, 2H, ArH), 6.96 (s, 1H), 6.88 (d, J = 8.4 Hz, 2H, ArH), 5.99-6.09 
29 
 
(m, 1H), 5.41 (d, J = 17.2 Hz, 1H), 5.29 (d, J = 10.4 Hz, 1H), 4.76 (s, 2H), 4.51 (s, 2H), 2.29 (s, 
3H). HRMS ESI (m/z): calcd. for C21H19F2N2O3 [M+H]
+, 385.1379; found 385.1377. 
 
(Z)-5-(3,5-difluoro-4-hydroxybenzylidene)-3-(3-hydroxybenzyl)-2-methyl-3,5-dihydro-4H-
imidazol-4-one 17. Yellow solid. 53% yield. 1H NMR (400 MHz, CD3OD): δ 7.82 (d, J = 10.0 
Hz, 2H, ArH), 7.17 (t, J = 8.0 Hz, 1H, ArH), 6.98 (s, 1H), 6.72 (d, J = 8.0 Hz, 2H, ArH), 6.64 (s, 
1H, ArH), 4.79 (s, 2H), 2.28 (s, 3H). HRMS ESI (m/z): calcd. for C18H15F2N2O3 [M+H]
+, 
345.1045; found 345.1050. 
 
(Z)-5-(3,5-difluoro-4-hydroxybenzylidene)-3-(4-iodobenzyl)-2-methyl-3,5-dihydro-4H-
imidazol-4-one 18. Yellow solid. 73% yield. 1H NMR (400 MHz, CD3OD): δ 7.82 (d, J = 10.0 
Hz, 2H, ArH), 7.73 (d, J = 8.4 Hz, 2H, ArH), 7.06 (d, J = 8.4 Hz, 2H, ArH), 6.98 (s, 1H), 4.83 (s, 
2H), 2.29 (s, 3H). HRMS ESI (m/z): calcd. for C18H14F2IN2O2 [M+H]
+, 455.0063; found 455.0074. 
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(Z)-5-(3,5-difluoro-4-hydroxybenzylidene)-3-(4-fluorobenzyl)-2-methyl-3,5-dihydro-4H-
imidazol-4-one 19. Yellow solid. 73% yield. 1H NMR (400 MHz, CD3OD): δ 7.81 (d, J = 9.6 Hz, 
2H, ArH), 7.28-7.32 (m, 2H, ArH), 7.10 (t, J = 8.8 Hz, 2H, ArH), 6.98 (s, 1H), 4.85 (s, 2H), 2.30 
(s, 3H). HRMS ESI (m/z): calcd. for C18H14F3N2O2 [M+H]
+, 347.1002; found 347.1008. 
 
(Z)-5-(3,5-difluoro-4-hydroxybenzylidene)-2-methyl-3-(2,4,6-trifluorobenzyl)-3,5-dihydro-
4H-imidazol-4-one 20. Yellow solid. 75% yield. 1H NMR (400 MHz, CD3OD): δ 7.79 (d, J = 9.6 
Hz, 2H, ArH), 6.90-6.95 (m, 2H, ArH), 6.89 (s, 1H), 4.91 (s, 2H), 2.38 (s, 3H). HRMS ESI (m/z): 
calcd. for C18H12F5N2O2 [M+H]
+, 383.0813; found 383.0820. 
 
(Z)-5-(3,5-difluoro-4-hydroxybenzylidene)-2-methyl-3-((perfluorophenyl)methyl)-3,5-
dihydro-4H-imidazol-4-one 21. Yellow solid. 71% yield. 1H NMR (400 MHz, CD3OD): δ 7.82 
(d, J = 9.6 Hz, 2H, ArH), 6.89 (s, 1H), 4.98 (s, 2H), 2.42 (s, 3H). HRMS ESI (m/z): calcd. for 
C18H10F7N2O2 [M+H]
+, 419.0625; found 419.0633. 
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(Z)-3-(4-(tert-butyl)benzyl)-5-(3,5-difluoro-4-hydroxybenzylidene)-2-methyl-3,5-dihydro-
4H-imidazol-4-one 22. Yellow solid. 71% yield. 1H NMR (400 MHz, CD3OD): δ 7.80 (d, J = 9.6 
Hz, 2H, ArH), 7.40 (d, J = 8.4 Hz, 2H, ArH), 7.17 (d, J = 8.4 Hz, 2H), 6.97 (s, 1H), 4.83 (s, 2H), 
2.28 (s, 3H), 1.30 (s, 9H). HRMS ESI (m/z): calcd. for C22H23F2N2O2 [M+H]
+, 385.1722; found 
385.1727. 
 
(Z)-5-(3,5-difluoro-4-hydroxybenzylidene)-3-(4-hydroxyphenethyl)-2-methyl-3,5-dihydro-
4H-imidazol-4-one 23. Yellow solid. 73% yield. 1H NMR (400 MHz, CD3OD): δ 7.77 (d, J = 9.6 
Hz, 2H, ArH), 6.97 (d, J = 8.4 Hz, 2H, ArH), 6.90 (s, 1H), 6.72 (d, J = 8.4 Hz, 2H, ArH), 3.81 (t, 
J = 6.8 Hz, 2H), 2.84 (t, J = 6.8 Hz, 2H), 1.96 (s, 3H). HRMS ESI (m/z): calcd. for C19H17F2N2O3 
[M+H]+, 359.1202; found 359.1210. 
 
(Z)-5-(3,5-difluoro-4-hydroxybenzylidene)-3-(4-fluorophenethyl)-2-methyl-3,5-dihydro-4H-
imidazol-4-one 24. Yellow solid. 69% yield. 1H NMR (400 MHz, CD3OD): δ 7.77 (d, J = 10.0 
Hz, 2H, ArH), 7.17-7.21 (m, 2H, ArH), 7.02 (t, J = 8.8 Hz, 2H, ArH), 6.89 (s, 1H), 3.85 (t, J = 6.8 
Hz, 2H), 2.93 (t, J = 6.8 Hz, 2H), 2.06 (s, 3H). 
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(Z)-5-(3,5-difluoro-4-hydroxybenzylidene)-3-(4-iodophenethyl)-2-methyl-3,5-dihydro-4H-
imidazol-4-one 25. Yellow solid. 70% yield. 1H NMR (400 MHz, CD3OD) δ 7.77 (d, J = 9.6 Hz, 
2H, ArH), 7.65 (d, J = 8.4 Hz, 2H, ArH), 6.99 (d, J = 8.4 Hz, 2H, ArH), 6.89 (s, 1H), 3.85 (t, J = 
6.8 Hz, 2H), 2.93 (t, J = 6.8 Hz, 2H), 2.08 (s, 3H). HRMS ESI (m/z): calcd. for C19H16F2IN2O2 
[M+H]+, 469.0219; found 469.0227. 
Procedure 3. General procedure for the functionalization of HBI at the allylic position. 
 
To solution of diisopropylamine (0.1 mL, 0.694 mmol) in THF (5 mL) was added 0.23 mL 
(0.578 mmol) of 2.5 M n-BuLi in hexane at -78 ºC under argon. In 10 min solution of HBI (0.050 
g, 0.231 mmol) in THF (20 mL) was added slowly. The reaction was stirred for 30 min. The 
appropriate electrophile (0.231 mmol) in THF (3 mL) was added slowly. The reaction was allowed 
to warm up to room temperature overnight. The reaction was quenched with 1M HCl. 50 mL of 
water was added. The product was extracted with ethyl acetate (3×50 mL). The organic layer was 
dried with MgSO4, filtered. The solvent was evaporated. The crude product was purified by 
preparative TLC. 
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5-((Z)-4-hydroxybenzylidene)-3-methyl-2-((E)-styryl)-3,5-dihydro-4H-imidazol-4-one 26. 
Orange solid. 91% yield. 1H NMR (400 MHz, CD3OD): δ 8.18 (d, J = 8.9 Hz, 2H, ArH), 8.09 (d, 
J = 15.7 Hz, 1H), 7.65 (dd, J = 7.5, 1.9 Hz, 2H, ArH), 7.43 (d, J = 7.8 Hz, 3H, ArH), 7.14 (s, 1H), 
6.91 (d, J = 8.8 Hz, 2H, ArH), 6.84 (d, J = 15.8 Hz, 1H), 3.34 (s, 3H). HRMS ESI (m/z): calcd. for 
C19H17N2O2 [M+H]
+, 305.1285; found 305.1285. 
 
2-((E)-4-fluorostyryl)-5-((Z)-4-hydroxybenzylidene)-3-methyl-3,5-dihydro-4H-imidazol-4-
one 27. Orange solid. 48% yield. 1H NMR (400 MHz, CD3OD): δ 8.19 (d, J = 8.8 Hz, 2H, ArH), 
8.07 (d, J = 15.9 Hz, 1H), 7.76 (d, J = 7.6 Hz, 2H, ArH), 7.41 – 7.46 (m, 4H), 7.12 (d, J = 15.9 
Hz, 1H), 7.08 (s, 1H), 3.34 (s, 3H). HRMS ESI (m/z): calcd. for C19H16FN2O2 [M+H]
+, 323.1190; 
found 305.1199. 
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5-((Z)-4-hydroxybenzylidene)-3-methyl-2-((1E,3E)-4-phenylbuta-1,3-dien-1-yl)-3,5-
dihydro-4H-imidazol-4-one 28. Orange solid. 63% yield. 1H NMR (400 MHz, CD3OD): δ 8.12 
(d, J = 8.6 Hz, 2H); 7.83 (dd, J = 15.0, 10.9 Hz, 1H); 7.57 (d, J = 7.3 Hz, 2H); 7.35 – 7.42 (m, 3H), 
7.14 – 7.23 (m, 1H), 7.09 (s, 1H), 7.03 (s, 1H), 6.87 (d, J = 8.7 Hz, 2H), 6.62 (d, J = 15.0 Hz, 1H), 
3.26 (s, 3H). HRMS ESI (m/z): calcd. for C21H19N2O2 [M+H]
+, 331.1441; found 331.1448. 
 
(Z)-2-(but-3-en-1-yl)-5-(4-hydroxybenzylidene)-3-methyl-3,5-dihydro-4H-imidazol-4-one 
29. Yellow solid. 44% yield. 1H NMR (400 MHz, CD3OD): δ 8.05 (d, J = 8.7 Hz, 2H, ArH), 7.01 
(s, 1H), 6.84 (d, J = 8.8 Hz, 2H, ArH), 6.00 (td, J = 16.9, 6.6 Hz, 1H), 5.17 (dd, J = 17.2, 1.7 Hz, 
1H), 5.06 (dd, J = 10.2, 1.5 Hz, 1H), 3.18 (s, 3H), 2.72 – 2.81 (m, 2H), 2.55 – 2.63 (m, 2H). 13C 
NMR (100 MHz, CDCl3): 26.8, 28.9, 30.7, 116.3, 116.7, 119.9, 127.1, 129.4, 135.8, 138.2, 161.5, 
165.3, 172.8. HRMS ESI (m/z): calcd. for C15H17N2O2 [M+H]
+, 257.1285; found 257.1289. 
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(Z)-5-(4-hydroxybenzylidene)-3-methyl-2-((phenylthio)methyl)-3,5-dihydro-4H-imidazol-4-
one 30. Yellow solid. 73% yield. 1H NMR (400 MHz, CD3OD): δ 7.87 (d, J = 8.7 Hz, 2H, ArH), 
7.50 (d, J = 6.9 Hz, 2H, ArH), 7.30 (t, J = 7.2 Hz, 2H, ArH), 7.26 (d, J = 7.1 Hz, 1H, ArH), 7.01 
(s, 1H), 6.79 (d, J = 8.7 Hz, 2H, ArH), 4.12 (s, 2H), 3.25 (s, 3H). 13C NMR (100 MHz, CDCl3): 
27.2, 33.06, 116.7, 126.8, 128.9, 130.1, 130.8, 133.2, 134.7, 136.0, 136.9, 161.1, 161.8, 172.4. 
HRMS ESI (m/z): calcd. for C18H17N2O2S [M+H]
+, 325.1005; found 325.1005. 
 
(Z)-2-(bis(phenylthio)methyl)-5-(4-hydroxybenzylidene)-3-methyl-3,5-dihydro-4H-
imidazol-4-one 31. Yellow solid. 15% yield. 1H NMR (400 MHz, CD3OD): δ 7.86 (d, J = 8.8 Hz, 
2H, ArH), 7.53 (dd, J = 6.4, 3.2 Hz, 4H, ArH), 7.32 (dd, J = 4.9, 1.8 Hz, 6H, ArH), 7.01 (s, 1H), 
6.77 (d, J = 8.7 Hz, 2H, ArH), 5.66 (s, 1H) 3.36 (s, 3H). 13C NMR (100 MHz, CDCl3): 27.8, 55.5, 
116.7, 126.8, 128.8, 130.0, 130.2, 131.7, 133.2, 135.1, 136.3, 160.0, 162.0, 172.4. HRMS ESI 
(m/z): calcd. for C24H20N2O2S2 [M+H]
+, 433.1039; found 433.1039. 
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(Z)-5-(4-hydroxybenzylidene)-3-methyl-2-((phenylselanyl)methyl)-3,5-dihydro-4H-
imidazol-4-one 32. Yellow solid. 55% yield. 1H NMR (400 MHz, CD3OD): δ 7.80 (d, J = 8.7 Hz, 
2H, ArH), 7.56 – 7.63 (m, 2H, ArH), 7.27 (dd, J = 5.1, 1.8 Hz, 3H, ArH), 6.97 (s, 1H), 6.77 (d, J 
= 8.8 Hz, 2H, ArH), 4.05 (s, 2H), 3.20 (s, 3H). 13C NMR (100 MHz, CDCl3): 23.6, 27.1, 116.7, 
126.9, 129.0, 129.6, 130.2, 132.6, 135.9, 136.2, 137.0, 161.7, 162.2, 172.3. HRMS ESI (m/z): 
calcd. for C18H17N2O2Se [M+H]
+, 367.0509; found 367.0513. 
 
5-((Z)-3,5-difluoro-4-hydroxybenzylidene)-3-methyl-2-((E)-styryl)-3,5-dihydro-4H-
imidazol-4-one 33. This compound was synthesized using procedure 3 with the exception that 
DFHBI was used in place of HBI. Yellow solid. 63% yield. 1H NMR (400 MHz, CD3OD): δ 8.17 
(d, J = 15.9 Hz, 1H), 8.06 (d, J = 9.9 Hz, 2H, ArH), 7.84 (dd, J = 7.6, 1.6 Hz, 2H, ArH), 7.47 (d, 
J = 7.6 Hz, 3H, ArH), 7.26 (d, J = 15.8 Hz, 1H), 6.91 (s, 1H). HRMS ESI (m/z): calcd. for 
C19H15F2N2O2 [M+H]
+, 341.1096; found 341.1102. 
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5-((Z)-4-((tert-butyldimethylsilyl)oxy)benzylidene)-3-methyl-2-((E)-styryl)-3,5-dihydro-4H-
imidazol-4-one 34. Yellow solid. 55% yield. This compound was prepared according to the 
literature procedure and showed spectroscopic data identical to previously reported.16 
 
5-((Z)-4-((tert-butyldimethylsilyl)oxy)benzylidene)-3-methyl-2-((E)-styryl)-3,5-dihydro-4H-
imidazol-4-one 35. Yellow solid. 26% yield. 1H NMR (400 MHz, CD3OD): δ 8.16 (d, J = 8.7 Hz, 
2H, ArH), 8.09 (d, J = 15.8 Hz, 1H), 7.64 (d, J = 6.4 Hz, 2H, ArH), 7.40-7.44 (m, 3H, ArH), 7.15 
(s, 1H), 6.92 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 15.8 Hz, 1H), 3.34 (s, 3H), 0.99 (s, 9H), 0.24 (s, 6H). 
HRMS ESI (m/z): calcd. for C25H31N2O2Si [M+H]
+, 419.2149; found 419.2161. 
 
tert-butyl (3-(aminomethyl)benzyl)carbamate 36. This compound was prepared according to 
the literature procedure and showed spectroscopic data identical to previously reported.17 
 
38 
 
tert-butyl ((4'-(aminomethyl)-[1,1'-biphenyl]-4-yl)methyl)carbamate 37. This compound was 
prepared according to the literature procedure.17 
 
tert-butyl (Z)-(3-((4-(3,5-difluoro-4-hydroxybenzylidene)-2-methyl-5-oxo-4,5-dihydro-1H-
imidazol-1-yl)methyl)benzyl)carbamate 38. This compound was prepared according to 
procedure 1. Yellow solid. 71% yield. 1H NMR (400 MHz, CD3OD): δ 7.81 (d, J = 9.8 Hz, 2H), 
7.32 (t, J = 7.9 Hz, 1H), 7.14-7.22 (m, 3H), 6.98 (s, 1H), 4.58 (bs, 2H, NH2), 4.17-4.23 (m, 3H), 
2.27 (s, 3H), 1.41 (s, 9H). 
 
tert-butyl (Z)-((4'-((4-(3,5-difluoro-4-hydroxybenzylidene)-2-methyl-5-oxo-4,5-dihydro-1H-
imidazol-1-yl)methyl)-[1,1'-biphenyl]-4-yl)methyl)carbamate 39. This compound was 
prepared according to procedure 1 and was used for coupling with cyanine dyes and biotin without 
further purification. Yellow solid. 71% yield. 1H NMR (400 MHz, CD3OD): δ 7.62 (d, J = 7.5 Hz, 
2H), 7.53 – 7.60 (m, 4H), 7.31 – 7.38 (m, 4H), 7.02 (s, 1H), 4.39 (s, 2H), 4.26 (s, 2H), 2.00 (s, 
3H), 1.41 (s, 9H). 
Procedure 3. General procedure for coupling of DFHBI derivatives with cyanine Cy3, Cy5 
dyes, biotin. 
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To DFHBI derivative (0.1 mmol) was added trifluoroacetic acid (2-3 mL). The reaction was stirred 
for 5 min. Trifluoroacetic acid was evaporated. The product was dried in vacuum. The crude was 
dissolved in DMF (2 mL). Triethylamine was added (0.1 mL) followed by the corresponding NHS 
ester (0.1 mmol in 2 mL of DMF). The reaction was stirred for 36 hours. The solvent was 
evaporated. The crude was purified by preparative TLC yielding the products in quantitative 
yields. 
 
DFHBI-3-aminobenzylamine-Cy3 40. HRMS ESI (m/z): calcd. for C50H52F2N5O9S2 [M-K
+]+, 
968.3180; found 968.3196. 
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DFHBI-3-aminobenzylamine-Cy5 41. HRMS ESI (m/z): calcd. for C52H54F2KN5O9S2 [M-K
+]+, 
994.3336; found 994.3304. 
 
DFHBI-diphenyldiamine-Cy5 42. HRMS ESI (m/z): calcd. for C57H58F2N5O3 [M]
+, 898.4502; 
found 898.4498. 
 
 
DFHBI-diphenyldiamine-Cy3 43. HRMS ESI (m/z): calcd. for C55H56F2N5O3 [M]
+, 872.4346; 
found 872.4348. 
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DFHBI-3-aminobenzylamine-biotin 44. HRMS ESI (m/z): calcd. for C29H32F2N5O4S [M+H]
+, 
583.2143; found 584.2147. 
 
DFHBI-diphenyldiamine-biotin 45. HRMS ESI (m/z): calcd. for C29H32F2N5O4S [M+H]
+, 
660.2456; found 660.2435. 
 
Procedure 4. General procedure for synthesis of NHS esters of fluorobenzoic acids. 
 
To a solution of fluorobenzoic acid (3.41 mmol) in dioxane (7 mL) was successively added N-
hydroxysuccinimide (0.4121 g, 3.58 mmol) and N,N’-dicylohexylcarbodiimide (0.7388 g, 3.58 
mmol). The reaction was stirred overnight. The formed white precipitate of N,N’- dicyclohexylurea 
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was filtered off. The solution of NHS ester in 1,4-dioxane was used in the next step. The yield of 
the synthesized NHS ester is quantitative according to TLC and 1H NMR analysis. 
Procedure 5. General procedure for labelling of tobramycin with fluorobenzoyl moiety. 
To a solution of tobramycin (0.1210 g, 0.259 mmol), triethylamine (0.18 mL) in water (3 mL) was 
added fluorobenzoic acid NHS ester (0.30 mL of 0.775 M solution in 1,4-dioxane) dropwise. The 
reaction mixture was stirred overnight under argon. The volatiles were evaporated in vacuum. The 
crude material was purified by preparative TLC (water - n-butanol – MeOH - NH4OH, (4:5:2:1) 
to afford the desired products in 85-93 % yields. 
 
Tobramycin 4-fluorobenzoic acid conjugate. HRMS ESI (m/z): calcd. for C25H41FN5O10 
[M+H]+, 590.2837; found 590.2825. 
 
Tobramycin pentafluorobenzoic acid conjugate. HRMS ESI (m/z): calcd. for C25H37F5N5O10 
[M+H]+, 662.2461; found 662.2455. 
Procedure 5. General procedure for labelling of tobramycin with cyanine Cy3, Cy5 dyes.  
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To tobramycin (3.8 mg, 0.811 mmol) in water (0.5 mL) was added triethylamine (0.2 mL) followed 
by Cy3 or Cy5 NHS ester (8.11 mmol) in DMF (0.5 mL). The reaction was stirred for 24 hrs. The 
volatiles were evaporated in vacuum. The crude material was purified by preparative TLC to yield 
cyanine-labelled tobramycin conjugates in quantitative yields. 
 
Tobramycin Cy3 conjugate 46. HRMS ESI (m/z): calcd. for C47H69N7O9 [M
+-CH2OH]
+, 
875.5151; found 875.5918. 
 
Tobramycin Cy3 conjugate 47. HRMS ESI (m/z): calcd. for C50H74N7O10 [M+H
++MeOH]+, 
965.5832; found 965.5807. 
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NHS ester of 4-hydroxyphenylpropionic acid 48. This compound was prepared using procedure 
4. 
 
Paromomycin 4-hydroxypropionic acid conjugate 49. White solid. Yield 76%. HRMS ESI 
(m/z): calcd. for C25H37F5N5O10 [M+H]
+, 764.3566; found 764.3552. 
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CHAPTER 2. RAPID ASSEMBLY OF THE PROCYANIDIN A-SKELETON 
This work has been published in Tetrahedron Letters in 2017 (Kraus, G. A.; Geraskin, I. M. 
Tetrahedron Letters, 2017, 58, 4609–4611.). 
 
Introduction 
Procyanidins are polyphenols that are present in various fruits, vegetables, plants, nuts, grains, 
grapes, red wine, green tea. They are very potent bioactive compounds. Procyanidins have been 
reported to exhibit antioxidative and free-radical scavenging,1 anti-inﬂammatory,2,3 anti-
infectious,4 antiviral,5 cardiovascular protective,6 anticancer properties.7,8 Procyanidins started to 
be used as natural and alternative medicines and products containing procyanidins appeared in the 
natural product market as dietary supplements in the 1980s.9 They are used as natural 
preservatives, stabilizers in foods and as natural antioxidants to prevent degradation of fatty 
acids.10,11 Procyanidins have been reported to be effective in the prevention of various degenerative 
diseases.12,13  
Procyanidins are a class of proanthocyanidins, which contain only catechin or epicatechin subunits 
structures of which are shown in Figure 1. 
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Procyanidins are classified into two types, A-type and B-type, depending on type of bonding 
between monomers. Subunits are linked by single bond between carbon-4 of one subunit and either 
carbon-8 or carbon-6 of another subunit in B-type procyanidins, as shown in Figure 2. 
 
B-type procyanidins are the most abundant in nature and procyanidins B1, B2, B3 and B4 
encounter most frequently. Being the largest type of procyanidins B-type procyanidins received 
considerably more attention compared to A-type procyanidins. There are many reports on the 
synthesis of B-type procyanidins. Most of the reported syntheses use the strategy outlined in 
Scheme 1. Two protected catechin or epicatechin molecules, with one bearing leaving group at 
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carbon-4, condense under acidic conditions forming the dimer. Upon deprotection the desired 
product, procyanidin is formed. 
 
A-type procyanidins are less abundant in nature and have received less attention from scientific 
community. Besides having bond between carbon-4 of one subunit and either carbon-8 or carbon-
6 of another subunit A-type procyanidins have second ether linkage between hydroxyl group of 
one subunit and carbon-2 of another subunit. The structures of some A-type procyanidins are 
depicted in Figure 3. Procyanidin A1, procyanidin A2 are the most common A-type procyanidins. 
Mahuannin D (11) showed hypotensive activity.14 Mahuannin E (12) exhibited cytotoxicity against 
SGC-7901, HepG2, and HeLa tumor cell lines.15 Geranin A (13) exhibits antiprotozoal activity in 
the mg/mL level.16 Ephedrannin B (14) suppressed the transcription of tumor necrosis factor-α and 
interleukin-1β.17  
 
50 
 
 
 
Because of valuable biological properties and low availability of A-type procyanidins from natural 
sources several synthetic approaches have been reported. Stereoselective synthesis of procyanidin 
A2 using Lewis acid-mediated annulation approach was reported by Ito, Ohmori and Suzuki in 
2014.18 Sharma and coworkers reported synthesis of proanthocyanidins A1 and A2 in 2015.19 
Convenient synthesis of A-type procyanidins from benzopyrilium salts was reported by Kraus, 
Yuan and Kempema in 2009.20 
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Results and discussion 
Valuable biological properties combined with low abundance in nature of type-A procyanidins 
encouraged us to develop convenient synthetic strategy towards this important class of compounds. 
We envisioned that retrosynthetically procyanidin A skeleton 17 can be derived from two 
molecules of phloroglucinol and acetylenic aldehyde 15.  Our synthetic strategy is outlined in 
Scheme 2. 
 
The starting aldehydes 24, 25, 26, 29 are readily available via a Sonogashira reaction of the 
corresponding aryl halide with propargyl alcohol followed by oxidation with MnO2, as illustrated 
in Scheme 3. Aldehyde 30 was obtained in good yield by treatment of phenylacetylene with n-
butyl lithium followed by the addition of N,N-Dimethylformamide. 
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We studied 17, the product from the reaction of 15 (R = OMe) with phloroglucinol and PTSA, 
using 1H NMR, 13C NMR, and 2D NMR. The resonance at 99.9 ppm in the 13C NMR spectrum 
confirmed the presence of an acetal or ketal. The correlation between the bridgehead carbon atom 
C12 at 21.2 ppm and hydrogen atom on C12 at 4.31 ppm in the HSQC spectrum confirmed that 
structure 17 was formed. The cross peaks at 4.31; 2.19 and 2.17; 4.33 in COSY indicate correlation 
between hydrogen atom on C12 and methylene hydrogens on adjacent carbon atom. In addition, 
the predicted NMR spectrum for ketal 17 resembled the spectrum we obtained from experiment. 
We think that the reaction occurs via two acid catalyzed additions of phloroglucinol to the carbonyl 
carbon of the acetylenic aldehyde followed by an intramolecular ketalization. 
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To find the best reaction conditions we evaluated a number of Lewis acid catalysts in the reaction 
of acetylenic aldehyde 15 with phloroglucinol, as depicted in Table 1. 
Table 1. Optimization of the reaction conditions 
 
Entry Acid Solvent Percent yield of 17 Percent yield of 31a (acetylated 
product) 
1 PTSA·H2O CH3CN 26 82 
2 PTSA·H2O THF 0  
3 PTSA·H2O DMF 0  
4 BF3·Et2O CH3CN 25 77 
5 TFA CH3CN 10  
6 HCl CH3CN  78 
7 H2SO4 CH3CN 12  
a Acetylation with acetic anhydride and pyridine. 
The product was obtained in the highest yield when PTSA was used as acid catalyst in acetonitrile, 
entry 1, Table 1. As seen in entries 1, 4, and 6, acetylation prior to purification significantly 
improved the isolated yields, presumably due to improved stability and solubility of the acetylated 
products. All reactions were carried out in acetonitrile at room temperature. There was no reaction 
in DMF or THF. Compound 31 can be prepared on a gram scale using this method. 
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To extend the scope of the reaction we evaluated different substitution patterns on the aromatic 
ring of the aldehyde using the best reaction conditions, PTSA/CH3CN. All reactions afforded good 
yields of products, as shown in Table 2. Compounds 32 and 33 were unstable on silica gel and 
should not be exposed to silica gel for prolonged period of time. 
Table 2. Reaction scope 
 
Entry Substrate 1 Substrate 2 Product Yield, % 
1 
  
 
82 31 
2 
 
 
 
54 32 
3 
 
 
 
56 33 
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Table 2. (continued)     
4 
  
 
61 34 
5 
  
 
67 35 
 
To further extend reaction scope phloroglucinol dimethyl ether and 2-methyl resorcinol were used 
as substrates under best reaction conditions, as shown in Scheme 4.  
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Unfortunately, products 36, 37 were unstable to column chromatography but reaction afforded 
good yields of products based on 1H NMR analysis of the crude reaction mixture. 
Many procyanidins such as 9 and 10 possess hydroxyl group on the one-carbon bridge. Efforts to 
oxidize the tetraacetate 31 by C-H activation using Cp2VCl2 and TBHP failed.
21 Fortunately, we 
found that dibromo aldehyde 38 reacts with two equivalents of phloroglucinol under best reaction 
conditions, PTSA/CH3CN, followed by acetylation to give tetraacetate 39 in 57% yield, as shown 
in Scheme 5. 
 
The dibromo aldehyde 38 can be synthesized in good yield by bromination of alkyne 21 followed 
by oxidation with MnO2, as depicted in Scheme 6. 
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Conclusion 
In summary, procyanidins are important class of natural products with valuable biological 
properties. A-type procyanidins are not abundant in nature and have to be synthesized in order for 
scientists to explore the full potential of these natural products. While there are many reports on 
the synthesis of B-type procyanidins A-type procyanidins are overlooked by scientific community 
and there are only a few reports on the synthesis of A-type procyanidins. 
We have developed convenient one-step procedure for the synthesis of procyanidin A-skeleton. 
Different alkynylaldehydes or dibromocinnamaldehydes and phloroglucinol derivatives can be 
used to make procyanidin A skeleton with various substitution patterns on aromatic rings using 
this procedure. The method is efficient and simple and can be useful for the total synthesis of A-
type procyanidins. Some compounds were prepared on a gram scale using this method. 
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Experimental Section 
All starting materials were purchased from Sigma-Aldrich; solvents were purchased from Fisher 
Scientific and used without further purification. All reactions were carried out in flame-dried 
glassware under argon with dry solvents under anhydrous conditions. All yields refer to 
chromatographically isolated products. Reactions were monitored by thin-layer chromatography 
(TLC) carried out on 0.20 mm silica gel plates using UV light as a visualizing agent. Silica gel 
60A, particle size 0.032 – 0.063 mm, was used for flash column chromatography. 1H and 13C NMR 
spectra were acquired in CDCl3 on a Varian MR-400 spectrometer. 
1H and 13C chemical shifts (δ) 
are given in ppm relative to the residual protonated solvent peak (CDCl3: δH = 7.26 ppm, δC = 
77.0 ppm; CD3OD: δH = 3.31 ppm, δC = 49.0 ppm) as an internal reference. High-resolution mass 
spectra (HRMS) were recorded on an Agilent 6540 QTOF (quadrupole time of flight) mass 
spectrometer using ESI (electrospray ionization) or APCI (atmospheric-pressure chemical 
ionization), or EI (electron ionization) on an Agilent 6890 GC/MS. IR were recorded on Nicolet 
Fisher Scientific iS5. Melting points were measured on Mel-Temp II melting point apparatus. 
 
 
 
 
 
 
 
59 
 
 
3-(4-methoxyphenyl)prop-2-yn-1-ol (21). Solid (5.64 g, 87% yield). This compound was 
prepared according to the literature procedure and showed spectroscopic data identical to 
previously reported.22 
 
3-(4-methoxyphenyl)propiolaldehyde (24). Yellow solid (0.8202 g, 83% yield). This compound 
was prepared according to the literature procedure and showed spectroscopic data identical to 
previously reported.22 
 
3-phenylpropiolaldehyde (30). Yellowish oil (1.2491 g, 78% yield). This compound was 
prepared according to the literature procedure and showed spectroscopic data identical to 
previously reported.23 
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3-(benzo[d][1,3]dioxol-5-yl)prop-2-yn-1-ol (28). Grey solid (0.3435 g, 65% yield). This 
compound was prepared according to the literature procedure and showed spectroscopic data 
identical to previously reported.24 
 
3-(benzo[d][1,3]dioxol-5-yl)propiolaldehyde (29). Yellow solid (0.1742 g, 75% yield). This 
compound was prepared according to the literature procedure and showed spectroscopic data 
identical to previously reported.25 
 
(E)-2,3-dibromo-3-(4-methoxyphenyl)prop-2-en-1-ol. Grey solid (1.0308 g, 91% yield). This 
compound was prepared according to the literature procedure and showed spectroscopic data 
identical to previously reported.26 
 
(E)-2,3-dibromo-3-(4-methoxyphenyl)acrylaldehyde (38). Grey solid (0.4923 g, 79% yield). 
This compound was prepared according to the literature procedure and showed spectroscopic data 
identical to previously reported.26 
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3-(4-nitrophenyl)prop-2-yn-1-ol (23). Light-brown solid (0.7146 g, 81% yield). This compound 
was prepared according to the literature procedure and showed spectroscopic data identical to 
previously reported.27 
 
3-(4-nitrophenyl)propiolaldehyde (26). Yellow solid (0.7146 g, 81% yield). This compound was 
prepared according to the literature procedure and showed spectroscopic data identical to 
previously reported.27 
 
3-(4-chlorophenyl)prop-2-yn-1-ol (22). Yellow solid (6.32 g, 91% yield). This compound was 
prepared according to the literature procedure and showed spectroscopic data identical to 
previously reported.28 
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3-(4-chlorophenyl)propiolaldehyde (25). Orange crystalline solid (1.4 g, 89% yield). This 
compound was prepared according to the literature procedure and showed spectroscopic data 
identical to previously reported.28 
 
 
6-(4-methoxyphenyl)-12H-6,12-methanodibenzo[d,g][1,3]dioxocine-1,3,9,11-tetraol (17): To 
a solution of 3-(4-methoxyphenyl)propiolaldehyde (0.085 g, 0.53 mmol) and phloroglucinol 
(0.268 g, 2.12 mmol) in acetonitrile (10 mL) was added PTSA · H2O (0.0101 g, 0.053 mmol). The 
solution immediately changed color to dark red. The reaction was stirred at room temperature 
under argon for 12 hours. The solvent was evaporated. The crude was purified by preparative TLC 
(CH2Cl2 – MeOH, 92:8) to yield 5 (0.0544 g, 26% yield) as red solid, m.p. 176-178 °C. IR: 3311, 
2942, 2830, 1021. 1H NMR (400 MHz, CD3OD): δ 2.19 (2H, d, J = 3.2 Hz, CH2), 3.83 (3H, s, 
OCH3), 4.31 (1H, t, J = 3.2 Hz, CH), 5.98 (2H, d, J = 2.4 Hz, ArH), 6.02 (2H, d, J = 2.4 Hz, ArH), 
6.98 (2H, d, J = 8.8 Hz, ArH), 7.60 (2H, d, J = 8.8 Hz, ArH). 13C NMR (100 MHz, CD3OD): 21.7, 
34.7, 55.7, 96.7, 97.4, 99.8, 107.8, 114.4, 128.1, 135.5, 154.5, 154.6, 158.2, 161.3. HRMS ESI 
(m/z): calcd. for C22H18O7 [M + H]
+, 395.1125; found 395.1109. 
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General procedure for the condensation reaction 
 
The preparation of compound 7 is representative.  
 
6-(4-methoxyphenyl)-12H-6,12-methanodibenzo[d,g][1,3]dioxocine-1,3,9,11-tetrayl 
tetraacetate (31): To a solution of 3-(4-methoxyphenyl)propiolaldehyde (0.085 g, 0.53 mmol) and 
phloroglucinol (0.268 g, 2.12 mmol) in acetonitrile (10 mL) was added PTSA · H2O (0.0101 g, 
0.053 mmol). The reaction was stirred at room temperature under argon for 12 hours. The solvent 
was evaporated. The crude was dissolved in a solution of pyridine (1.9 mL) and acetic anhydride 
(2 mL). The resulting solution was stirred overnight at room temperature under argon. The reaction 
solution was poured into ice-cold water (20 mL) and extracted with ethyl acetate (3 × 25 mL). The 
combined organic fractions were washed with water (2 × 20 mL), brine (20 mL), dried over 
MgSO4, filtered, solvent was evaporated. The crude product was purified by preparative TLC 
(EtOAc – Hex, 70:30) to yield tetraacetate 7 (0.245 g, 82% yield) as grey solid, m.p. 156-158 °C. 
IR: 3056, 2933, 1768, 1264, 1194. 1H NMR (400 MHz, CDCl3): δ 2.24 (6H, s, 2CH3), 2.27-2.28 
(2H, m, CH2), 2.41 (6H, s, 2CH3), 3.83 (3H, s, OCH3), 4.25 (1H, t, J = 2.8 Hz, CH), 6.53 (2H, d, 
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J = 2.4 Hz, ArH), 6.73-6.74 (2H, m, ArH), 6.93-6.96 (2H, m, ArH), 7.55-7.59 (2H, m, ArH). 13C 
NMR (100 MHz, CDCl3): 21.2, 21.6, 23.1, 33.0, 55.5, 99.1, 108.4, 109.4, 113.8, 115.8, 127.1, 
132.3, 147.7, 150.0, 154.0, 160.2, 169.0, 169.2. HRMS ESI (m/z): calcd. for C30H27O11 [M + H]
+, 
563.1553; found 563.1548. 
Table 3. Screening of different acids for the condensation reaction. 
Entry Acid Isolated yield, % Isolated yield after acetylation, % 
1 PTSA ·H2O 26 82 
2 BF3·Et2O 25 77 
3 TFA 10  
4 HCl  78 
5 H2SO4 12  
 
 
6-phenyl-12H-6,12-methanodibenzo[d,g][1,3]dioxocine-1,3,9,11-tetrayl tetraacetate (32): 
Grey solid (0.0977 g, 54% yield), m.p. 89-91 °C. IR: 3057, 1766, 1185. 1H NMR (400 MHz, 
CDCl3): δ 2.25 (6H, s, 2CH3), 2.29-2.30 (2H, m, CH2), 2.42 (6H, s, 2CH3), 4.25 (1H, t, J = 3.0 Hz, 
CH), 6.53 (2H, d, J = 2.4 Hz, ArH), 6.75 (2H, d, J = 2.4 Hz, ArH), 7.40-7.44 (3H, m, ArH), 7.66 
(2H, dd, J = 8.0 Hz, ArH). 13C NMR (100 MHz, CDCl3): 21.2, 21.6, 23.0, 33.0, 53.6, 99.1, 108.4, 
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109.5, 115.8, 125.7, 128.6, 129.3, 140.1, 147.7, 150.1, 153.9, 168.9, 169.1. HRMS ESI (m/z): 
calcd. for C29H24O10 [M + H]
+, 533.1442; found 533.1441. 
 
 
6-(benzo[d][1,3]dioxol-5-yl)-12H-6,12-methanodibenzo[d,g][1,3]dioxocine-1,3,9,11-tetrayl 
tetraacetate (33): Light brown solid (0.0561 g, 56% yield), m.p. 108-110 °C. 1H NMR (400 MHz, 
CDCl3): δ 1.89 (3H, s, CH3), 2.04 (3H, s CH3), 2.27 (2H, br s, CH2), 2.38 (3H, s, CH3), 4.68-4.70 
(1H, m, CH), 5.92-5.93 (2H, m, CH2), 6.31-6.32 (1H, m, ArH), 6.69 (2H, d, J = 6.8 Hz, ArH), 
6.72-6.73 (1H, m, ArH), 6.94-6.96 (2H, m, ArH), 7.01-7.02 (1H, m, ArH). 13C NMR (100 MHz, 
CDCl3): 19.7, 20.8, 20.9, 21.3, 29.9, 46.2, 101.3, 102.2, 105.4, 114.0, 114.4, 114.7, 115.2, 119.9, 
121.1, 134.6, 137.1, 140.1, 146.6, 147.0, 149.3, 149.5, 149.7, 150.3, 150.4, 150.7, 168.1, 168.4, 
169.1, 169.3. HRMS ESI (m/z): calcd. for C30H25O12 [M + H]
+, 577.1341; found 577.1335. 
 
 
6-(4-chlorophenyl)-12H-6,12-methanodibenzo[d,g][1,3]dioxocine-1,3,9,11-tetrayl 
tetraacetate (34). Yellow solid (0.1066 g, 61% yield), m.p. 238-239 °C. 1H NMR (400 MHz, 
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CDCl3): δ 2.04 (6H, s, 2CH3), 2.04-2.25 (2H, m, CH2), 2.42 (6H, s, 2CH3), 4.24-4.26 (1H, m, CH), 
6.53-6.54 (1H, m, ArH), 6.74-6.75 (1H, m, ArH), 7.42 (2H, d, J = 8.7 Hz, ArH), 7.58 (2H, d, J = 
8.7 Hz, ArH). 13C NMR (100 MHz, CDCl3): 21.2, 21.5, 22.9, 32.9, 98.7, 108.4, 109.6, 115.7, 
127.3, 128.7, 135.3, 138.7, 147.8, 150.1, 153.6, 168.9, 169.1. HRMS ESI (m/z): calcd. for 
C28H27O7 [M + H]
+, 567.1053; found 567.1061. 
 
 
6-(4-nitrophenyl)-12H-6,12-methanodibenzo[d,g][1,3]dioxocine-1,3,9,11-tetrayl tetraacetate 
(35): Light-grey crystalline solid (0.024 g, 67% yield), m.p. 173-175 °C. 1H NMR (400 MHz, 
CDCl3): δ 1.86 (6H, s, 2CH3), 2.25 (6H, s, 2CH3), 2.28-2.29 (2H, m, CH2), 4.11-4.17 (1H, m, CH), 
6.82 (2H, s, ArH), 6.89-6.90 (2H, m, ArH), 7.16-7.18 (2H, m, ArH), 7.35 (2H, d, J = 8.0 Hz, ArH), 
8.09 (2H, d, J = 8.0 Hz, ArH). 13C NMR (100 MHz, CDCl3): 169.0, 168.6, 150.8, 150.1, 149.6, 
146.9, 134.8, 129.7, 127.7, 123.9, 123.0, 120.6, 114.7, 36.0, 29.8, 21.2, 20.9. HRMS ESI (m/z): 
calcd. for C29H22NO12 [M – H+]-, 576.1147; found 576.1158. 
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13-bromo-6-(4-methoxyphenyl)-12H-6,12-methanodibenzo[d,g][1,3]dioxocine-1,3,9,11-
tetrayl tetraacetate (39): Grey solid (0.1448 g, 57% yield), m.p. 53-55 °C. 1H NMR (400 MHz, 
CDCl3): δ 2.25 (3H, s, CH3), 2.27 (3H, s, CH3), 2.27 (3H, s, CH3), 2.40 (3H, s, CH3), 2.45 (3H, s, 
CH3), 3.86 (3H, s, OCH3), 4.52 (2H, s, CHBr, CH), 6.56-6.57 (1H, m, ArH), 6.66-6.68 (1H, m, 
ArH), 6.87-6.89 (1H, m, ArH), 6.95 (2H, d, J = 8.0 Hz, ArH), 7.52-7.55 (1H, m, ArH), 7.60 (2H, 
d, J = 8.0 Hz, ArH). 13C NMR (100 MHz, CDCl3): 21.3, 21.6, 32.6, 46.2, 55.5, 98.8, 108.1, 112.0, 
113.6, 116.0, 128.2, 129.7, 146.9, 149.4, 150.5, 150.7, 152.2, 153.5, 160.6, 168.6, 169.1. HRMS 
ESI (m/z): calcd. for C30H26BrO11 [M + H]
+, 643.0638; found 643.0673. 
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CHAPTER 3. SYNTHETIC ANTHOCYANIDINS FROM NATURAL BENZOPYRANS 
This work has been published in Natural Product Communications in 2016 (Kraus, G. A.; 
Geraskin, I. M. Natural Product Communications 2016, 11, 1649-1650.). 
 
Introduction 
Anthocyanins are ionic polycyclic natural products. They are present in a variety of fruits 
and vegetables including blueberries, currants, cherries, grapes, raspberries, gooseberries and 
certain varieties of sweet potatoes. This class of compounds has been reported to exhibit a broad 
array of biological activities. There are number of excellent reviews describing antioxidant 
properties of anthocyanins.1-3 Anthocyanins from red cabbage were reported to show a strong 
protective effect against oxidative damage of platelet biomolecules induced by biological 
oxidants.4 Blueberry anthocyanins showed inhibition of acrylamide-induced toxicity in mice by 
preventing oxidative stress and cytochrome P450 2E1 activation.5 Cherry anthocyanins were 
reported to inhibit polyphenol oxidase enzyme activity.6 Anthocyanins were suggested as potential 
candidates for the treatment of diabetic retinopathy.7 During World War II British pilots were fed 
blueberries to improve their night vision. The French paradox, observation that there is relatively 
low occurrence of coronary heart disease among French people who consume red wine on regular 
basis, was attributed to the presence of anthocyanins present in red wine which act as radical 
scavengers. Because of their valuable biological properties several methods of isolation and 
purification of anthocyanins from plant extracts have been developed. Researchers employed 
various techniques such as mechanical shaking, countercurrent chromatography, and enrichment 
on macroporous resins to purify anthocyanins.8-10 All these purification methods were not effective 
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in separating procyanidins from other polyphenols. Furthermore, because of low abundance of 
procyanidins in natural sources large amounts of natural materials are required to obtain necessary 
amounts of procyanidins for research studies. 
Anthocyanidins are aglycones of anthocyanins, sugar-free counterparts of anthocyanins. 
Some representative compounds are shown in Figure 1. 
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About 30% of anthocyanidins found in nature contain cyanidin, 22% contain delphinidin, 
and 18% contain pelargonidin. Around 20% of the anthocyanins are based on peonidin, malvidin, 
and petunidin.11 Most of the anthocyanidins contain hydroxyl group at carbon-3 through which 
they are connected to sugar moiety. Some anthocyanins, mostly those present in bryophytes, 
contain 3-desoxyanthocyanidins, apigenidin, diosmetnidin, luteolinidin, tricetinidin, columidin, 
compounds 13-17. 
Because of the valuable biological properties and low abundance of anthocyanidins from 
natural sources to explore the full potential of these compounds several syntheses were reported. 
Most of them used synthetic approach developed by Robinson which involves the reaction of a 
substituted acetophenone with an aromatic aldehyde in the presence of a concentrated solution of 
gaseous hydrochloric acid.12 The representative example is shown in Scheme 1. 
 
While this method worked on a small scale and a number of anthocyanidins were prepared 
by this method, there are potential hazards associated with the use of gaseous hydrochloric acid. 
We sought for a more convenient procedure, not requiring the use of hazardous reagents and 
preparation of aromatic precursors. 
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Results and discussion 
There are many benzopyran-containing natural products which are more readily available 
than anthocyanidins and have very similar structural motives to anthocyanidins. These products 
can be possibly converted to anthocyanidins under the right reaction conditions. There a few 
transformations of this type which have been reported. Rutin, a flavonol glycoside, was reduced 
by Bruillard and coworkers with zinc amalgam in 3% absolute methanolic hydrochloric acid to 
give the corresponding cyanidin glycoside.13 The synthesis of cyanidin 3-O-β-D-glucoside from 
(+)-catechin was reported by Kondo and coworkers.14 The key intermediate, dihydroanthocyanin, 
was oxidized by air in hydrogen chloride-methanol to generate cyanidine glycoside. Although air 
was employed to oxidize dihydroanthocyanidins, there are no reports of its application to oxidize 
more reduced precursors. Dihydroanthocyanidin was oxidized to anthocyanidin with chloranil in 
moderate yield by Sweeny and Iacobucci.15 
The optimal oxidant would convert benzopyrans cleanly into anthocyanidins without traces 
of the oxidant contaminating the product. The product anthocyanidin should be easily separated 
and purified from the crude reaction mixture because this type of compounds is very labile to many 
purification methods such as silica gel column chromatography. To be sustainable, the oxidants 
should be used in catalytic amounts and must be capable to be regenerated by environmentally 
friendly oxidants. 
We explored triphenylcarbenium tetrafluoroborate, also called trityl tetrafluoroborate, a 
well-known hydride abstractor, shown in Figure 2. Trityl tetrafluoroborate is a yellow solid which 
is soluble in most organic solvents such as tetrahydrofuran, dichloromethane and reacts with 
nucleophilic solvents. 
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Trityl tetrafluoroborate has been used in organic syntheses in dehydrogenation reactions, 
deprotection of ketone acetals, oxidation of silyl enol ethers.16-19 It had not been used in the 
synthesis of anthocyanidins. The byproduct of the oxidation is triphenylmethane, a hydrocarbon, 
which can be simply separated from the highly polar products by trituration. Also, 
triphenylmethane can be possibly re-oxidized to make the process catalytic. 
Reaction of epicatechin directly with trityl tetrafluoroborate afforded mostly trityl aryl 
ether formation plus small amounts of product. Acetylation of hydroxyl groups prior to the hydride 
abstraction significantly increased the yield of the flavylium salt. Also, changing the solvent from 
dichloromethane to 1,2-dichloroethane improved the yield of the desired product. Treatment of 
epicatechin pentaacetate 19 with trityl tetrafluoroborate in 1,2-dichloroethane afforded flavylium 
tetrafluoroborate salt 20 that is upon treatment with hydrochloric acid in ethanol produced cyanidin 
chloride 6 in 93% yield, as depicted in Scheme 2. 
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Similarly, delphinidin chloride 2 was synthesized in 65% yield by treatment of 
epigallocatechin gallate peracetate 21 with trityl tetrafluoroborate followed by treatment of the 
resulting tetrafluoroborate salt 22 with hydrochloric acid in ethanol as illustrated in Scheme 3. 
 
This process can be extended to the preparation of isoflavylium salts. The diacetate of 
commercially available equol 23 was refluxed with trityl tetrafluoroborate in dichloroethane 
followed by treatment with hydrochloric acid in ethanol to afford isoflavylium salt 25 in 69 % 
yield, as shown in Scheme 4. 
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Conclusion 
In summary, anthocyanins are important class of potent biological molecules. They were 
reported to have tremendous number of biological activities. There are hundreds of known 
anthocyanins which have been isolated from natural sources. Scientists isolate about 20-30 new 
anthocyanins yearly. Anthocyanins structurally consist of anthocyanidin part, which is believed to 
be responsible for all valuable biological properties anthocyanins possess, and sugar moiety. 
Because of valuable biological properties and low abundance from natural sources efficient 
syntheses of anthocyanins need to be developed to study this important class of natural products. 
There are many readily available benzopyran-containing natural products which have 
chemical structures very close to structures of anthocyanidins. We have explored the reactivity of 
different benzopyran derivatives which are structurally close to known anthocyanidins. We have 
discovered that trityl tetrafluoroborate can be used to synthesize anthocyanidins in good yields. 
The process is operationally convenient and can be used to prepare anthocyanidins in gram 
quantities for biological evaluation. 
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Experimental Section 
All starting materials were purchased from Sigma-Aldrich; solvents were purchased from Fisher 
Scientific and used without further purification. All reactions were carried out in flame-dried 
glassware under argon with dry solvents under anhydrous conditions. All yields refer to 
chromatographically isolated products. Reactions were monitored by thin-layer chromatography 
(TLC) carried out on 0.20 mm silica gel plates using UV light as a visualizing agent. Silica gel 
60A, particle size 0.032 – 0.063 mm, was used for flash column chromatography. 1H and 13C NMR 
spectra were acquired in CDCl3 on a Varian MR-400 spectrometer. 
1H and 13C chemical shifts (δ) 
are given in ppm relative to the residual protonated solvent peak (CDCl3: δH = 7.26 ppm, δC = 
77.0 ppm; CD3OD: δH = 3.31 ppm, δC = 49.0 ppm) as an internal reference. High-resolution mass 
spectra (HRMS) were recorded on an Agilent 6540 QTOF (quadrupole time of flight) mass 
spectrometer using ESI (electrospray ionization) or APCI (atmospheric-pressure chemical 
ionization), or EI (electron ionization) on an Agilent 6890 GC/MS. IR were recorded on Nicolet 
Fisher Scientific iS5. Melting points were measured on Mel-Temp II melting point apparatus. 
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Pentaacetyl (-)-epicatechin (19). To 0.5000 g of (-)epichatechin (1.72 mmol) in 6 mL of pyridine 
was added 2 mL of acetic anhydride at 0 °C. The reaction was stirred overnight at room 
temperature under argon. The solution was then partitioned between 50 mL of ethyl acetate:50 mL 
of 1N HCl. The organic layer was washed with 1N HCl (3 × 50 mL), water (50 mL), brine (50 
mL). The washed organic layer was dried over MgSO4, filtered, solvent was evaporated. The crude 
product was triturated with hexane to provide 0.7286 g of (-)-epicatechin pentaacetate at 85% 
yield. 1H NMR (400 MHz, CDCl3): δ 1.92 (3H, s, COCH3), 2.28 (3H, s, COCH3), 2.30 (9H, s, 
COCH3), 2.87 (1H, dd, J = 18.0 Hz, H-4a), 2.99 (1H, dd, J = 18.0 Hz, H-4b), 5.11 (1H, s, H-2), 
5.38-5.40 (1H, m, H-3), 6.57 (1H, d, J = 2.2 Hz, H-6 or H-8), 6.67 (1H, d, J = 2.2 Hz, H-6 or H-
8), 7.20 (1H, d, J = 8.4 Hz, H-9), 7.27 (1H, dd, J = 8.4 Hz, H-10), 7.36 (1H, d, J = 2.0 Hz, H-11). 
 
 
Cyanidin chloride (6). To a solution of (-)-epicatechin pentaacetate (0.1000 g, 0.2 mmol) in DCE 
(2 mL) was added solution of triphenylcarbenium tetrafluoroborate (0.1319 g, 0.4 mmol) in DCE 
(5 mL). The reaction was refluxed overnight. DCE was evaporated. The residue was dissolved in 
ethanol (7 mL) and concentrated HCl (2 mL) was added. The reaction was refluxed overnight. 
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Volatiles were evaporated. Crude was triturated with diethyl ether to yield 0.0603 g of cyanidin 
chloride in 93% yield. 1H NMR (400 MHz, CD3OD): δ 6.61 (1H, s, ArH), 6.85 (1H, s, ArH), 7.01 
(1H, d, J = 8.8 Hz, ArH), 8.10 (1H, s, ArH), 8.22 (1H, dd, J = 8.8 Hz, ArH), 8.55 (1H, s, ArH). 
HRMS ESI (m/z): calcd. for C15H11O6
+ [M]+, 287.0550; found 287.0550. 
 
 
Epigallocatechin gallate (EGCG) peracetate (21). EGCG (0.0407 g, 0.089 mmol) was dissolved 
in a solution of pyridine (0.6 mL) and acetic anhydride (0.7 mL). The reaction was stirred at 45 °C 
in an oil bath under argon for 20 h. The reaction was then poured into ice-cold water (10 mL) and 
was left to stand for 1 h to form a white precipitate. The resulting precipitate was filtered, dried. 
The crude product was purified by preparative TLC (EtOAc – Hex, 70:30) to yield 0.0466g of 
EGCG peracetate in 67 % yield. 1H NMR (400 MHz, CDCl3): δ 2.23 (6H, s, COCH3), 2.25 (3H, 
s, COCH3), 2.27 (3H, s, COCH3), 2.28 (9H, s, COCH3), 2.29 (3H, s, COCH3), 2.98 (1H, dd, J = 
17.8 Hz, H-4a), 3.08 (1H, dd, J = 17.8 Hz, H-4b), 5.19 (1H, s, H-2), 5.62-5.64 (1H, m, H-3), 6.61 
(1H, d, J = 2.2 Hz, H-6 or H-8), 6.73 (1H, d, J = 2.2 Hz, H-6 or H-8), 7,24 (2H, s, H-7), 7.62 (2H, 
s, H-9). 
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Delphinidin chloride (2). To a solution of EGCG peracetate (0.0466 g, 0.059 mmol) in DCE (1 
mL) was added solution of triphenylcarbenium tetrafluoroborate (0.0388 g, 0.118 mmol) in DCE 
(3 mL). The reaction was refluxed overnight. DCE was evaporated. The residue was dissolved in 
ethanol (5 mL) and concentrated HCl (1 mL) was added. The reaction was refluxed overnight. 
Volatiles were evaporated. Crude was triturated with diethyl ether to yield 0.0603 g of delphinidin 
chloride in 65% yield. 1H NMR (400 MHz, CD3OD): δ 5.80 (1H, s, ArH), 5.99 (1H, s, ArH), 6.60 
(1H, s, ArH), 6.83 (2H, s, ArH). HRMS ESI (m/z): calcd. for C15H11O7
+ [M]+, 303.0499; found 
303.0500. 
 
 
4’,7-diacetoxyisoflavan (23). (±)-Equol (0.0430 g, 0.177 mmol) was dissolved in a solution of 
pyridine (0.7 mL) and acetic anhydride (0.7 mL). The reaction was stirred at room temperature 
overnight. The reaction solution was poured into ice-cold water (10 mL) and extracted with 
dichloromethane (3 × 10 mL). The combined organic layers were washed with water (2 × 20 mL), 
brine (20 mL), dried over MgSO4, filtered, solvent was evaporated to yield 0.0424g (73%) of 4’,7-
diacetoxyisoflavan. 1H NMR (400 MHz, CDCl3): δ 2.29 (3H, s, COCH3), 2.31 (3H, s, COCH3), 
3.01 (2H, d, J = 8.4 Hz, ArCH2), 3.21-3.29 (1H, m, ArCH), 3.98-4.03 (1H, m, OCH), 4.35 (1H, 
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dd, J = 10.4 Hz, OCH), 6.61-6.64 (2H, m, ArH), 7.06-7.09 (3H, m, ArH), 7.25 (2H, d, J = 7.2 Hz, 
ArH). 
 
 
7-hydroxy-3-(4-hydroxyphenyl)chromenylium chloride (25). To a solution of (±)-equol 
diacetate (0.0416 g, 0.127 mmol) in DCE (2 mL) was added solution of triphenylcarbenium 
tetrafluoroborate (0.0842 g, 0.255 mmol) in DCE (5 mL). The reaction was refluxed overnight. 
DCE was evaporated. The residue was dissolved in ethanol (7 mL) and concentrated HCl (1.5 mL) 
was added. The reaction was refluxed overnight. Volatiles were evaporated. Crude was triturated 
with diethyl ether to yield 0.0603 g of 7-hydroxy-3-(4-hydroxyphenyl)chromenylium chloride in 
69% yield. 1H NMR (400 MHz, CD3OD): δ 7.08-7.2 (3H, m, ArH), 7.16-7.21 (3H, m, ArH), 7.24-
7.29 (3H, m, ArH). HRMS ESI (m/z): calcd. for C15H11O6
+ [M+ - H+ + Na+ + C2H5OH]
+, 307.0934; 
found 307.1332. 
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GENERAL CONCLUSION 
New methods for the syntheses of natural products and molecules for RNA imaging have 
been described in this dissertation. In Chapter 1 we have shown the synthesis of library of small 
molecules which can be used for RNA imaging. PFP-DFHBI, the best synthesized compound, has 
been found to have superior qualities compared to commonly used DFHBI ligand. The synthesized 
compounds can be used as either light-up aptamers or in FRET for the visualization of gene 
expression. We have successfully coupled some of the most promising compounds to cyanine dyes 
Cy3 and Cy5 to generate FRET pairs and to biotin to select new RNA aptamers from a pool of 
RNAs. We have developed the procedure to functionalize allylic position in DFHBI with different 
electrophiles. This method was used for the synthesis of DFHBI analogs with extended 
conjugation which have been found to have different excitation and emission wavelengths and 
longer fluorescence lifetime compared to DFHBI. The studies are currently ongoing to explore the 
full potential of these compounds. We have developed an efficient method for labelling of 
aminoglycosides. This procedure is used by our collaborators at the University of California San 
Francisco to track bacteria in soil. 
In chapter 2 we describe one-step procedure for the synthesis of procyanidin A-skeleton. 
Different alkynylaldehydes or dibromocinnamaldehydes were coupled with phloroglucinol 
derivatives to afford procyanidin A skeleton with various substitution patterns on aromatic rings 
using this method. The method is simple, efficient, was performed on a large scale and will be 
used for the total synthesis of A-type procyanidins. 
I chapter 3 we explored the reactivity of natural benzopyrans and have found that they can 
be converted in one pot to anthocyanidins in good yields with the use of trityl tetrafluoroborate. 
The synthesized anthocynidins are easily purified from non-polar byproduct triphenylmethane. 
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The method is efficient and simple and can be used to prepare anthocyanidins in gram quantities 
for biological evaluation. 
This work resulted in three articles published in peer-reviewed journals. Two or three additional 
publications are in preparation. 
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